Cyclica Inc. is awarded access to IBM’s Blue Gene supercomputer to repurpose FDA approved drugs

TORONTO, Canada – July 2, 2013 – Cyclica Inc. has been awarded access to IBM’s Blue Gene supercomputer to optimize drug discovery and development using existing drugs that have been… Continue reading Cyclica Inc. is awarded access to IBM’s Blue Gene supercomputer to repurpose FDA approved drugs

RIC Client Intronix Technologies Corp. recieves FDA Clearance for MyoGuideâ„¢

TORONTO, March 30, 2012 Reposted from Bloomberg Businessweek Great things come in small packages, or at least that’s what leading neurologists, physiatrists and clinicians are now discovering with the revolutionary… Continue reading RIC Client Intronix Technologies Corp. recieves FDA Clearance for MyoGuideâ„¢